The glucocorticoid receptor as a potential target to reduce cocaine abuse

Journal of Neuroscience

Volumn 23, Issue 11, 2003, Pages 4785-4790

  Deroche Gamonet, Véronique ^a   Sillaber, Inge ^b   Aouizerate, Bruno ^a   Izawa, Ryozuke ^a   Jaber, Mohamed ^a   Ghozland, Sandy ^a   Kellendonk, Christoph ^c   Le Moal, Michel ^a   Spanagel, Rainer ^d   Schütz, Günther ^c   Tronche, François ^c,e   Piazza, Pier Vincenzo ^a  

^a INSERM   (France)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e l'alimentation et l'Environnement   (France)

Author keywords

c Fos; Cocaine; Glucocorticoid receptor; Intravenous; Mifepristone; Self administration; Sensitization; Transgenic

Indexed keywords

COCAINE; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG EXPOSURE; DRUG SELF ADMINISTRATION; DRUG SENSITIZATION; GENE INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

EID: 0038456111     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-11-04785.2003     Document Type: Article

References (50)

1. Badiani A, Morano MI, Akil H, Robinson TE (1995) Circulating adrenal hormones are not necessary for the development of sensitization to the psychomotor activating effects of amphetamine. Brain Res 673:13-24.
2. Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000) The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12:973-979.
3. Barrot M, Abrous DN, Marinelli M, Rouge-Pont F, Le Moal M, Piazza PV (2001) Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum. Eur J Neurosci 13:812-818.
4. Baulieu EE (1989) Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 245:1351-1357.
5. Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857.
6. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218.
7. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
8. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997) Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous selfadministration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281:1401-1407.
9. Deroche V, Le Moal M, Piazza PV (1999) Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur J Neurosci 11:2731-2736.
10. De Vries TJ, Schoffelmeer AN, Tjon GH, Nestby P, Mulder AH, Vanderschuren LJ (1996) Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur J Pharmacol 307:R3-R4.
11. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
12. Gagne D, Pons M, Philibert D (1985) RU 38486: a potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem 23:247-251.
13. Goeders NE (2002) The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27:13-33.
14. Goeders NE, Guerin GF (1996) Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 722:145-152.
15. Hafezi-Moghadam A, Simoncini T, Yang E, Limbourg FP, Plumier JC, Rebsamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock AJ, Laubach VE, Moskowitz MA, French BA, Ley K, Liao JK (2002) Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-479.
16. Haney M, Ward AS, Foltin RW, Fischman MW (2001) Effects of ecopipam, a selective dopamine Di antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 155:330-337.
17. Herrlich P (2001) Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465-2475.
18. Hyman SE, Cole RL, Konradi C, Kosofsky BE (1995) Dopamine regulation of transcription factor-target interactions in rat striatum. Chem Senses 20:257-260.
19. Jaber M, Dumartin B, Sagne C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11:3499-3511.
20. Karin M, Chang L (2001) AP-1-glucocorticoid receptor crosstalk taken to a higher level. J Endocrinol 169:447-451.
21. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680-687.
22. Koob GF, Weiss F (1990) Pharmacology of drug self-administration. Alcohol 7:193-197.
23. Lorrain DS, Arnold GM, Vezina P (2000) Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res 107:9-19.
24. Makara GB, Haller J (2001) Non-genomic effects of glucocorticoids in the neural system: evidence, mechanisms and implications. Prog Neurobiol 65:367-390.
25. Mantsch JR, Goeders NE (1999) Ketoconazole blocks the stress-induced reinstatement of cocaine-seeking behavior in rats: relationship to the discriminative stimulus effects of cocaine. Psychopharmacology 142:399-407.
26. Marinelli M, Piazza PV, Deroche V, Maccari S, Le Moal M, Simon H (1994) Corticosterone circadian secretion differentially facilitates dopaminemediated psychomotor effect of cocaine and morphine. J Neurosci 14:2724-2731.
27. Marinelli M, Rouge-Pont F, Deroche V, Barrot M, De Jesus-Oliveira C, Le Moal M, Piazza PV (1997) Glucocorticoids and behavioral effects of psychostimulants. I. Locomotor response to cocaine depends on basal levels of glucocorticoids. J Pharmacol Exp Ther 281:1392-1400.
28. McEwen BS, De Kloet ER, Rostene W (1986) Adrenal steroid receptors and actions in the nervous system. Physiol Rev 66:1121-1188.
29. Mendrek A, Blaha CD, Phillips AG (1998) Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology 135:416-422.
30. Nann-Vernotica E, Donny EC, Bigelow GE, Walsh SL (2001) Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155:338-347.
31. Nestler EJ (1993) Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol 7:23-39.
32. Nestler EJ (2001) Molecular basis of long-term plasticity under lying addiction. Nat Rev Neurosci 2:119-128.
33. Piazza PV, Le Moal M (1997) Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev 25:359-372.
34. Piazza PV, Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67-74.
35. Piazza PV, Deminiere J-M, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513.
36. Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H (1991) Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88:2088-2092.
37. Piazza PV, Deroche V, Deminiere JM, Maccari S, Le Moal M, Simon H (1993) Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation - seeking behaviors. Proc Natl Acad Sci USA 90:11738-11742.
38. Piazza PV, Rouge-Pont F, Deroche V, Maccari S, Simon H, Le Moal M (1996) Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci USA 93:8716-8720.
39. Piazza PV, Deroche-Gamonet V, Rouge-Pont F, Le Moal M (2000) Vertical shifts in self-administration dose-response functions predict a drugvulnerable phenotype predisposed to addiction. J Neurosci 20:4226-4232.
40. Prasad BM, Ulibarri C, Kalivas PW, Sorg BA (1996) Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization. Psychopharmacology 125:265-273.
41. Przegalinski E, Filip M, Siwanowicz J, Nowak E (2000) Effect of adrenalectomy and corticosterone on cocaine-induced sensitization in rats. J Physiol Pharmacol 51:193-204.
42. Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug selfadministration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11.
43. Rivet JM, Stinus L, Le Moal M, Mormede P (1989) Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res 498:149-153.
44. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
45. Sapolsky RM, Romero LM, Munck AU (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89.
46. Schenk S, Partridge B (1997) Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 57:543-550.
47. Schuster CR, Thompson T (1969) Self administration of and behavioral dependence on drugs. Annu Rev Pharmacol 9:483-502.
48. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schütz G (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23:99-103.
49. Vanderschuren LJ, Schoffelmeer AN, Mulder AH, De Vries TJ (1999) Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology 143:244-253.
50. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N (2002) Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22:4654-4662.